Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1187 results about "Pyrophosphoric acid" patented technology

Pyrophosphoric acid, also known as diphosphoric acid, is the inorganic compound with the formula H₄P₂O₇ or, more descriptively, [(HO)₂P(O)]₂O. Colorless and odorless, it is soluble in water, diethyl ether, and ethyl alcohol. The anhydrous acid crystallizes in two polymorphs, which melt at 54.3 °C and 71.5 °C. The compound is not particular useful, except that it is a component of polyphosphoric acid and the conjugate acid of the pyrophosphate anion. Anions, salts, and esters of pyrophosphoric acid are called pyrophosphates.

Method of detecting primer extension reaction, method of discriminating base type, device for discriminating base type, device for detecting pyrophosphate, method of detecting nucleic acid and tip for introducing sample solution

Convenient techniques for discriminating the base type in a base sequence of a nucleic acid are provided. The technique includes the step (a) of preparing a sample solution containing a nucleic acid, a primer having a base sequence that includes a complementary binding region which complementarily binds to the nucleic acid, and a nucleotide; the step (b) of allowing the sample solution to stand under a condition to cause an extension reaction of the primer, and producing pyrophosphate when the extension reaction is caused; the step (c) of bringing the sample solution into contact with the front face of a H+ hardly permeable membrane having H+-pyrophosphatase, which penetrates from front to back of the membrane, of which active site that hydrolyzes pyrophosphate being exposed to the front face; the step (d) of measuring the H+ concentration of at least either one of the solution at the front face side of the H+ hardly permeable membrane or the solution at the back face side of the H+ hardly permeable membrane, in a state where the H+-pyrophosphatase is immersed in the solution; the step (e) of detecting the extension reaction on the basis of the result of measurement in the step (d) ; and the step (f) of discriminating the base type in the base sequence of the nucleic acid on the basis of the result of detection in the step (e).
Owner:PANASONIC CORP

Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection

Processes are disclosed using the depolymerization of a nucleic acid hybrid and incorporation of a suitable nucleotide to qualitatively and quantitatively analyze for the presence of predetermined nucleic acid target sequences. Applications of those processes include the detection of single nucleotide polymorphisms, identification of single base changes, genotyping, medical marker diagnostics, mirosequencing, and.
Owner:PROMEGA

Method for producing flame-retardant glued board

The invention discloses a method for producing a flame-retardant veneer plywood, which comprises the following steps: placing wood veneers into a flame retardant aqueous solution to perform dipping treatment, applying the mixed adhesive to the upper surfaces and the lower surfaces of the veneers after the veneers are dried, assembling the veneers into a plate blank according to the principle that odd layers are crossed and symmetrical with even layers, and then performing the processes of cold pressing, hot pressing, cutting edge, sanding, surface treating and the like to obtain the flame-retardant veneer plywood product the thickness of which is between 2.7 and 20 millimeters. The flame retardant in the method is a mixture of low ammonium polyphosphate, ammonium phosphate, ammonium pyrophosphate, urea phosphate, boric acid and pentaerythritol, and the mixed adhesive is a uniform mixture of wood adhesive, filler, and a curing agent. The flame-retardant decorative veneer plywood prepared by the method has the advantages of excellent flame-retardant and fireproof performance, environmental prevention performance, and good mechanical properties.
Owner:DEHUA TB NEW DECORATION MATERIAL CO LTD

Pyrosequencing Methods and Related Compositions

This invention provides methods for pyrosequencing and compositions comprising 3′-O— modified deoxynucleoside triphosphates.
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK

Loaded V-P-O catalyst and its prepn and use

The catalyst consists of loaded vanadium and phosphor oxide and SiO2 carrier formed via pyrogenic decomposition with the loaded amount being 15-58 wt%. It has a V / P atom ratio of 1.2, specific area 117-210 sq m / g, and the main phase being vanadyl pyrophosphate phase. It is used as the catalyst for air oxidizing n-butane to prepare cis-butenedioic anhydride and has one single-path conversion rate of 33-51 % and cis-butenedioic anhydride selectivity of 61-87 % in the typical temperature range of 380-400 deg.c.
Owner:NANJING UNIV

Construction and application of farnesyl pyrophosphoric acid synthetase RNA (Ribonucleic Acid) interference recombinant lentivirus vector

InactiveCN101805750AOvercoming No Commercial AntibodyOvercoming low transfection efficiencyMetabolism disorderGenetic material ingredientsDiseaseFhit gene
The invention provides the construction for a farnesyl pyrophosphoric acid synthetase RNA (Ribonucleic Acid) interference recombinant lentivirus vector, which comprises the following steps of: sieving the most effective target sequence of an FDS (farnesyl diphosphate synthase) gene RNAi (RNA interference) in a tool cell 293T cell, synthesizing the double-stranded DNA of the most effective target sequence, connecting to a pGCSIL-GFP vector and successfully constructing the recombinant vector through enzyme cutting, sequencing and identification. Researches indicate that the constructed RNA interference vector LV-sh-FDS can downwards modulate the expression of an FDS mRNA (Messenger RNA) level in a neonatal rat cardiac myocyte, simultaneously can downwards modulate the expression of myocardial hypertrophy markers such as cell areas and marker genes beta-MHC (Myosin Heavy Chain) and BNP (Brain Natriuretic Peptide), additionally can effectively inhabit the activity of RhoA while downwards modulating the FDS, can be applied in preparing medicaments for treating myocardial hypertrophy diseases and also can be applied in preparing medicaments for cholesterol metabolic control.
Owner:ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products